Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;140(1):53-7.
doi: 10.1016/j.ygyno.2015.11.004. Epub 2015 Nov 4.

Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases

D Callegaro-Filho  1 , D M Gershenson  2 , A M Nick  2 , M F Munsell  3 , P T Ramirez  2 , P J Eifel  4 , E D Euscher  5 , R M Marques  6 , S M Nicolau  6 , K M Schmeler  7
Affiliations

Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases

D Callegaro-Filho et al. Gynecol Oncol. 2016 Jan.

Abstract

Objective: Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT) is a rare disease with a poor prognosis. SCCOHT has recently been shown to be associated with SMARCA4 gene mutations as well as molecular and genetic similarities to malignant rhabdoid tumors (MRT). The objective of our study is to describe the clinical characteristics, treatment modalities and outcomes of 47 patients with SCCOHT.

Methods: We performed a retrospective analysis of 47 patients with SCCOHT evaluated at MD Anderson Cancer Center between 1990 and 2014. Medical records were reviewed for demographic information, pathologic findings, treatment regimens and outcomes.

Results: Median age at diagnosis was 30 years (range 5-46). All patients underwent surgery with unilateral salpingo-oophorectomy (USO) performed in 26 patients (55%), and hysterectomy with bilateral salpingooophorectomy (BSO) in 21 patients (45%). Sixteen patients (34.0%) had stage I disease, six (12.8%) stage II, 23 (48.9%) stage III, and two patients (4.3%) had stage IV disease. Information on adjuvant treatment was available for 43 patients: 83.3% received chemotherapy alone, 9.5% chemotherapy followed by radiotherapy, 2.4% chemoradiation, and 4.8% did not receive any adjuvant therapy. Median follow-up was 13.2 months (range, 0.1 to 210.7) with a median overall survival of 14.9 months. Multi-agent chemotherapy and radiotherapy were associated with a better prognosis.

Conclusion: Our findings suggest that aggressive therapy including multi-agent chemotherapy and possibly radiotherapy may extend survival. Further study is needed to improve outcomes in these patients including the adoption of systemic therapies used in MRT as well as the development of novel agents targeting specific mutations.

Keywords: Hypercalcemic type; Malignant rhabdoid tumor; Radiotherapy; SMARCA4; Small cell carcinoma of the ovary; VPCBAE.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Figures

Figure 1
Figure 1
Overall survival
See this image and copyright information in PMC

References

    1. Young RH, Oliva E, Scully RE. Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases. Am J Surg Pathol. 1994;18:1102–16. - PubMed
    1. Estel R, Hackethal A, Kalder M, et al. Small cell carcinoma of the ovary of the hypercalcaemic type: an analysis of clinical and prognostic aspects of a rare disease on the basis of cases published in the literature. Arch Gynecol Obstet. 2011;284:1277–82. - PubMed
    1. Florell SR, Bruggers CS, Matlak M, et al. Ovarian small cell carcinoma of the hypercalcemic type in a 14 month old: the youngest reported case. Med Pediatr Oncol. 1999;32:304–7. - PubMed
    1. Shrimali RK, Correa PD, Reed NS. Dose-dense and dose-intense chemotherapy for small cell ovarian cancer: 2 cases and review of literature. Med Oncol. 2011;28:766– 70. - PubMed
    1. Dykgraaf RH, de Jong D, van Veen M, et al. Clinical management of ovarian small- cell carcinoma of the hypercalcemic type: a proposal for conservative surgery in an advanced stage of disease. Int J Gynecol Cancer. 2009;19:348–53. - PubMed

Publication types